Cargando…

A Review of the Role of Bioreactors for iPSCs-Based Tissue-Engineered Articular Cartilage

BACKGROUND: Osteoarthritis (OA) is the most common degenerative joint disease without an ultimate treatment. In a search for novel approaches, tissue engineering (TE) has shown great potential to be an effective way for hyaline cartilage regeneration and repair in advanced stages of OA. Recently, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reina-Mahecha, Alejandro, Beers, Martine J., van der Veen, Hugo C., Zuhorn, Inge S., van Kooten, Theo G., Sharma, Prashant K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645985/ https://www.ncbi.nlm.nih.gov/pubmed/37861960 http://dx.doi.org/10.1007/s13770-023-00573-6

Ejemplares similares

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

iPSCs: A powerful tool for skeletal muscle tissue engineering
por: del Carmen Ortuño‐Costela, María, et al.
Publicado: (2019)

Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression
por: Broeders, M., et al.
Publicado: (2022)

Comparative evaluation of isogenic mesodermal and ectomesodermal chondrocytes from human iPSCs for cartilage regeneration
por: Lee, Ming-Song, et al.
Publicado: (2021)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
por: Gähwiler, Eric K. N., et al.
Publicado: (2021)

Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
por: Nam, Yoojun, et al.
Publicado: (2017)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Application of an acoustofluidic perfusion bioreactor for cartilage tissue engineering
por: Li, Siwei, et al.
Publicado: (2014)

Pneumatic piston hydrostatic bioreactor for cartilage tissue engineering
por: Hallas, J., et al.
Publicado: (2022)

Tissue engineering of functional articular cartilage: the current status
por: Kock, Linda, et al.
Publicado: (2011)

Application-Oriented Bulk Cryopreservation of Human iPSCs in Cryo Bags Followed by Direct Inoculation in Scalable Suspension Bioreactors for Expansion and Neural Differentiation
por: Meiser, Ina, et al.
Publicado: (2023)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

The Role of Extracellular Matrix Expression, ERK1/2 Signaling and Cell Cohesiveness for Cartilage Yield from iPSCs
por: Buchert, Justyna, et al.
Publicado: (2019)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

A multi-well bioreactor for cartilage tissue engineering experiments
por: Ladner, Yann D., et al.
Publicado: (2023)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls
por: Zhao, Weihua, et al.
Publicado: (2020)

A tissue-engineered artificial human thymus from human iPSCs to study T cell immunity
Publicado: (2022)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fl8rakapn8m75bbbvim7sv0o3a